Sun Pharmaceutical Industries Ltd.

₹1,734.90

up-down-arrow-5.20 (-0.30%)

As on 16-May-2025 15:59IST

Value Research Rating

4 star

Quality Score fund-quick-summary-circle

0/0

Growth Score fund-quick-summary-circle

0/0

Valuation Score fund-quick-summary-circle

0/0

Momentum Score fund-quick-summary-circle

0/0

Sun Pharmaceutical Industries Ltd. Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 1,719.00 High: 1,741.60

52 Week Range

Low: 1,377.20 High: 1,960.35

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Market capMarket cap information

    ₹4,16,273 Cr

  • Revenue (TTM)Revenue (TTM) information

    ₹51,603 Cr

  • Net Profit (TTM)Net Profit (TTM) information

    ₹11,434 Cr

  • ROEROE information

    16.1 %

  • ROCEROCE information

    17.6 %

  • P/E RatioP/E Ratio information

    36.4

  • P/B RatioP/B Ratio information

    5.8

  • Industry P/EIndustry P/E information

    36.41

  • EV/EBITDAEV/EBITDA information

    24.7

  • Div. YieldDiv. Yield information

    0.8 %

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹300.2

  • EPSEPS information

    ₹49.2

  • Face valueFace value information

    1

  • Shares outstandingShares outstanding information

    2,399,334,970

10 Years Aggregate

CFO

₹64,291.40 Cr

EBITDA

₹87,158.11 Cr

Net Profit

₹52,845.20 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Sun Pharmaceutical
-8.0 1.8 2.0 13.6 25.3 31.1 6.2
BSE Sensex
5.2 7.3 8.4 12.8 16.0 21.5 11.7
BSE Healthcare
-6.0 2.8 6.4 20.7 23.9 23.1 9.9
As on 16-May-2025
Company
2024
2023
2022
2021
2020
2019
2018
Sun Pharmaceutical
49.7 25.8 18.4 41.8 36.4 -0.2 -25.0
BSE Sensex
8.1 18.7 4.4 22.0 15.8 14.4 5.9
BSE Healthcare
43.1 37.0 -12.1 20.9 61.4 -3.5 -5.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Sun Pharmaceutical
1,734.9 4,16,272.6 51,602.5 11,486.1 23.1 17.8 36.4 5.8
30,560.0 64,939.7 6,409.2 1,414.4 25.3 36.5 45.9 15.3
5,221.0 62,424.9 12,756.6 2,197.5 17.2 19.8 29 5.1
1,201.2 69,803.6 30,921.8 3,500.3 15.8 11.8 20 2.2
1,499.9 1,21,121.8 27,547.6 5,291.1 21.9 17.7 23 3.9
1,230.7 1,02,679.7 32,643.9 5,703.5 20.7 17.6 18.2 3.1
2,068.4 94,444.3 22,707.9 3,306.3 18.0 20 28.8 5.5
2,572.7 1,05,962.5 11,641.0 2,050.7 21.0 20.5 51.9 7.6
3,266.8 1,10,487.2 11,302.0 1,862.0 25.2 25.9 59.3 13.8
902.7 90,862.9 22,247.4 4,595.0 25.3 21.8 20 4.0

Shareholding Pattern

View Details
loading...

News & Analysis

All News

About Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations...  in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.  Read more

  • Incorporated

    1993

  • Chairman

    Dilip S Shanghvi

  • Managing Director

    Dilip S Shanghvi

  • Group

    Sun Pharma

  • Headquarters

    Vadodara, Gujarat

  • Website

    www.sunpharma.com

Edit peer-selector-edit

Quarterly Updates

Announcements

View Announcements

FAQs for Sun Pharmaceutical Industries Ltd.

The total asset value of Sun Pharmaceutical Industries Ltd stood at ₹ 88,116 Cr as on 31-Dec-24

The share price of Sun Pharmaceutical Industries Ltd is ₹1,734.90 (NSE) and ₹1,734.95 (BSE) as of 16-May-2025 15:59 IST. Sun Pharmaceutical Industries Ltd has given a return of 25.27% in the last 3 years.

Sun Pharmaceutical Industries Ltd has a market capitalisation of ₹ 4,16,273 Cr as on 16-May-2025. As per Value Research classification, it is a Large Cap company.

The P/B ratio of Sun Pharmaceutical Industries Ltd is 5.78 times as on 16-May-2025, a 8% premium to its peers’ median range of 5.37 times.

The P/E ratio of Sun Pharmaceutical Industries Ltd is 36.41 times as on 16-May-2025, a 0% premium to its peers’ median range of 36.41 times.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Sun Pharmaceutical Industries Ltd and enter the required number of quantities and click on buy to purchase the shares of Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

The promoters of Sun Pharmaceutical Industries Ltd are Shanghvi Finance Private Limited and Dilip.S.Shanghvi. They collectively own 49.9 per cent of the total equity. The chairman of the company is Dilip S Shanghvi

The promoters of Sun Pharmaceutical Industries Ltd have pledged 0.48% of the total equity as on Mar-25.

Some of the close peers are:

Company Market Cap(₹ Cr)
1,21,122
1,10,487
1,05,963
1,02,680
94,444
90,863
69,804
64,940
62,425
Sun Pharmaceutical Industries Ltd. Ratios
Return on equity(%)
17.76
Operating margin(%)
23.06
Net Margin(%)
21.39
Dividend yield(%)
0.78

Yes, TTM profit after tax of Sun Pharmaceutical Industries Ltd was ₹11,434 Cr.